Rani Therapeutics raises $20M through sale of 12.5M shares and 6.2M warrants at $1.07

Filed May 27, 2026 · Period ending May 26, 2026 · ~1 min read

Key Changes

• high

  Rani sold 12.5 million shares and pre-funded warrants for 6.2 million more shares to institutional investors at $1.07 each, raising ~$20M before fees. The warrants are immediately exercisable at $0.0001, functioning essentially as common stock.

  Item 1.01 view on EDGAR →
• medium

  Company agreed to 90-day restriction on issuing new shares and 9-month ban on variable rate transactions, protecting new investors from immediate dilution and preventing potentially harmful financing structures.

  Item 1.01 view on EDGAR →
• medium

  Directors, officers, and certain stockholders entered 60-day lock-up agreements preventing them from selling shares, signaling management confidence and preventing insider selling pressure immediately after the offering.

  Item 1.01 view on EDGAR →